Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

RUSHED ddI APPROVAL MAY SET PRECEDENT

Oct. 10, 1991

SOMATIX CLAIMS GENE THERAPY RIGHTS

Oct. 10, 1991

ANALYST BOOSTS BIOGEN RATING

Oct. 10, 1991

ALLIANCE SECONDARY RAISES $59 MILLION

Oct. 10, 1991

LIFE OBTAINS RIGHTS TO STAINING TECHNOLOGY

Oct. 10, 1991

AMERICAN BIOGENETIC TO REDEEM WARRANTS

Oct. 10, 1991

CELL GENESYS AT CENTER OF AIDS RESEARCH

Oct. 10, 1991

AMEX TO TRADE SIX BIOTECH STOCKS

Oct. 10, 1991

SPAIN APPROVES BTGC'S GROWTH HORMONE

Oct. 9, 1991

CANCER TREATMENT COMBINES THERAPIES

Oct. 9, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...